(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Cardiff Oncology, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Thursday, April 25th, 2024 | 2023 | Fairooz Kabbinavar, CMO | 443,865 | 0 | 0 | 0 | 0 | 443,865 |
| Thursday, April 25th, 2024 | 2023 | Mark Erlander, CEO | 594,400 | 0 | 0 | 0 | 0 | 594,400 |
| Thursday, April 25th, 2024 | 2023 | James Levine, CFO | 459,236 | 0 | 0 | 0 | 0 | 459,236 |
| Thursday, April 27th, 2023 | 2022 | Tod Smeal, CSO | 402,716 | 40,000 | 0 | 156,825 | 0 | 599,541 |
| Thursday, April 27th, 2023 | 2022 | Mark Erlander, CEO | 570,600 | 0 | 0 | 266,475 | 0 | 837,075 |
| Thursday, April 27th, 2023 | 2022 | James Levine, CFO | 440,475 | 0 | 0 | 168,252 | 0 | 608,727 |
| Thursday, April 14th, 2022 | 2021 | James Levine, CFO | 202,693 | 0 | 0 | 179,775 | 0 | 382,468 |
| Thursday, April 14th, 2022 | 2020 | Mark Erlander, CEO | 444,764 | 0 | 0 | 229,559 | 0 | 674,323 |
| Thursday, April 14th, 2022 | 2021 | Vicki Kelemen, COO | 359,962 | 0 | 0 | 152,280 | 0 | 512,242 |
| Thursday, April 14th, 2022 | 2021 | Mark Erlander, CEO | 532,716 | 0 | 0 | 250,510 | 0 | 783,226 |
| Thursday, April 14th, 2022 | 2020 | Vicki Kelemen, COO | 322,576 | 0 | 0 | 157,500 | 0 | 480,076 |
| Wednesday, April 28th, 2021 | 2020 | Thomas H. Adams, Executive Chairman | 475,304 | 0 | 0 | 226,964 | 0 | 1,375,188 |
| Wednesday, April 28th, 2021 | 2019 | Thomas H. Adams, Executive Chairman | 491,132 | 0 | 0 | 244,625 | 0 | 1,304,634 |
| Wednesday, April 28th, 2021 | 2020 | Vicki Kelemen, COO | 322,576 | 0 | 0 | 157,500 | 0 | 749,619 |
| Wednesday, April 28th, 2021 | 2020 | Mark Erlander, CEO | 444,764 | 0 | 0 | 229,559 | 0 | 1,150,703 |
| Wednesday, April 28th, 2021 | 2019 | Mark Erlander, CEO | 398,729 | 0 | 0 | 198,600 | 0 | 852,951 |
| Wednesday, March 4th, 2020 | 2019 | Thomas H. Adams, CEO | 491,132 | 0 | 0 | 244,625 | 0 | 1,304,634 |
| Wednesday, March 4th, 2020 | 2019 | Mark Erlander, CSO | 398,729 | 0 | 0 | 198,600 | 0 | 852,951 |
| Friday, April 19th, 2019 | 2017 | William Welch, former CEO | 475,000 | 0 | 1,123,314 | 811,388 | 0 | 2,409,702 |
| Friday, April 19th, 2019 | 2018 | Mark Erlander, CSO | 387,155 | 0 | 34,785 | 342,576 | 0 | 908,524 |
| Friday, April 19th, 2019 | 2018 | William Welch, former CEO | 630,152 | 0 | 0 | 0 | 0 | 769,564 |
| Friday, April 19th, 2019 | 2018 | Thomas H. Adams, CEO | 286,346 | 0 | 0 | 79,167 | 0 | 377,192 |
| Friday, April 19th, 2019 | 2017 | Mark Erlander, CSO | 374,400 | 0 | 296,252 | 125,229 | 0 | 1,021,747 |
| Friday, April 27th, 2018 | 2017 | Dr. Mark Erlander, CSO | 374,400 | 0 | 296,252 | 125,229 | 0 | 1,021,747 |
| Friday, April 27th, 2018 | 2017 | William Welch, CEO | 475,000 | 0 | 1,123,314 | 811,388 | 0 | 2,409,702 |
| Friday, April 27th, 2018 | 2016 | Dr. Mark Erlander, CSO | 374,400 | 0 | 199,500 | 234,000 | 0 | 1,266,066 |
| Friday, April 28th, 2017 | 2014 | Dr. Mark Erlander, CSO | 298,769 | 0 | 0 | 131,200 | 0 | 1,351,369 |
| Friday, April 28th, 2017 | 2014 | Dr. Antonius Schuh, Former CEO | 385,000 | 0 | 0 | 154,000 | 0 | 938,999 |
| Friday, April 28th, 2017 | 2015 | Dr. Antonius Schuh, Former CEO | 470,000 | 0 | 0 | 211,500 | 0 | 681,500 |
| Friday, April 28th, 2017 | 2015 | Stephen Zaniboni, Former CFO | 317,708 | 0 | 0 | 146,250 | 0 | 463,958 |
| Friday, April 28th, 2017 | 2014 | Stephen Zaniboni, Former CFO | 242,000 | 0 | 0 | 96,800 | 0 | 602,200 |
| Friday, April 28th, 2017 | 2016 | William Welch, CEO | 319,712 | 0 | 0 | 115,781 | 0 | 3,639,787 |
| Friday, April 28th, 2017 | 2016 | Dr. Antonius Schuh, Former CEO | 29,574 | 0 | 0 | 0 | 0 | 2,733,425 |
| Friday, April 28th, 2017 | 2016 | Stephen Zaniboni, Former CFO | 94,768 | 0 | 0 | 0 | 0 | 552,934 |
| Friday, April 28th, 2017 | 2016 | Dr. Mark Erlander, CSO | 374,400 | 0 | 199,500 | 234,000 | 0 | 1,266,066 |
| Friday, April 28th, 2017 | 2015 | Dr. Mark Erlander, CSO | 372,246 | 0 | 0 | 162,000 | 0 | 534,246 |
| Thursday, March 31st, 2016 | 2013 | Stephen Zaniboni, Former CFO | 201,750 | 0 | 0 | 132,000 | 0 | 826,477 |
| Thursday, March 31st, 2016 | 2015 | Dr. Mark Erlander, CSO | 372,246 | 0 | 0 | 162,000 | 0 | 534,246 |
| Thursday, March 31st, 2016 | 2015 | Stephen Zaniboni, Former CFO | 317,708 | 0 | 0 | 146,250 | 0 | 463,958 |
| Thursday, March 31st, 2016 | 2015 | Dr. Antonius Schuh, Former CEO | 470,000 | 0 | 0 | 211,500 | 0 | 681,500 |
| Thursday, March 31st, 2016 | 2014 | Dr. Mark Erlander, CSO | 298,769 | 0 | 0 | 131,200 | 0 | 1,351,369 |
| Thursday, March 31st, 2016 | 2014 | Dr. Antonius Schuh, Former CEO | 385,000 | 0 | 0 | 154,000 | 0 | 938,999 |
| Thursday, March 31st, 2016 | 2013 | Dr. Antonius Schuh, Former CEO | 323,125 | 0 | 0 | 210,000 | 0 | 1,746,089 |
| Thursday, March 31st, 2016 | 2014 | Stephen Zaniboni, Former CFO | 242,000 | 0 | 0 | 96,800 | 0 | 602,200 |
| Thursday, March 31st, 2016 | 2013 | Dr. Mark Erlander, CSO | 169,692 | 0 | 0 | 100,000 | 0 | 1,635,879 |
| Thursday, March 31st, 2016 | 2015 | Matthew Posard, CCO | 256,250 | 0 | 0 | 116,199 | 0 | 2,191,275 |
| Tuesday, February 28th, 2006 | 2005 | V. Randy White, Ph.D, former Chief Executive Officer | 62,019 | 0 | 0 | 0 | 0 | 62,019 |
